Magnetic resonance spectroscopy: Principles and applications in neurosurgery

British Journal of Neurosurgery

Volumn 23, Issue 1, 2009, Pages 5-13

  McLean, Mary A ^a,b   Cross, Justin J ^b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Choline; Creatine; Epilepsy; Lactate; Magnetic resonance spectroscopy; Myo inositol; N acetyl aspartate; Traumatic brain injury; Tumor

Indexed keywords

CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTAMINE; GLYCEROPHOSPHORYLCHOLINE; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID; PHOSPHORYLCHOLINE;

BRAIN TUMOR; CARBON NUCLEAR MAGNETIC RESONANCE; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; FLUORINE NUCLEAR MAGNETIC RESONANCE; FRONTAL LOBE EPILEPSY; HUMAN; MACROMOLECULE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; RELIABILITY; REVIEW; TEMPORAL LOBE EPILEPSY; TRAUMATIC BRAIN INJURY;

BRAIN; BRAIN DISEASES; CLINICAL PROTOCOLS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NEUROSURGERY; NEUROSURGICAL PROCEDURES;

EID: 61649126537     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.1080/02688690802491673     Document Type: Review

References (52)

1. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-9.
2. Allen PS, Thompson RB, Wilman AH. Metabolite-specific NMR spectroscopy in vivo. NMR Biomed 1998;10:435-44.
3. Srinivasan R, Vigneron D, Sailasuta N, Hurd R, Nelson S. A comparative study ofmyo-inositol quantification using LCModel at 1.5 T and 3.0 T with 3D1H proton spectroscopic imaging of the human brain. Magn Reson Imaging 2004;22:523-8.
4. Frahm J, Bruhn H, Gynbgell ML, Merboldt KD, Hanick W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989;9:79-93.
5. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 1987;508:333-48.
6. Doddrell DM, Galloway G, Brooks W, Field J, Bulsing J, Irving M, Baddely H. Water signal elimination in vivo using suppression by mistimed echo and repetitive gradient episodes. J Magn Reson 1986;70:176-80.
7. Brown TR, Kincaid BM, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci USA 1982;79:3523-6.
8. Nicoli F, Vion-Dury J, Confort-Gouny S, Maillet S, Gastaut J-L, Cozzome PJ. Cerebrospinal fluid metabolic profiles in multiple sclerosis and degenerative dementias obtained by high resolution proton magnetic resonance spectroscopy. CR Acad Sci Paris 1996;319:623-31.
9. McLean MA, Woermann FG, Barker GJ, Duncan JS. Quantitative analysis of short echo time 1H-MRSI of cerebral grey and white matter. Magn Reson Med 2000;44:401-11.
10. Noworolski SM, Nelson SJ, Henry RG, Day MR, Wald LL, Star-Lack J, Vigneron DB. High spatial resolution 1H-MRSI and segmented MRI of cortical gray matter and subcortical white matter in three regions of the human brain. Magn Reson Med 1999;41:21-9.
11. Clayton DB, Elliot MA, Leigh JS, Lenkinski RE. 1H spectroscopy without solvent suppression: characterization of signal modulations at short echo times. JMagn Reson 2001;153:203-9.
12. Howe FA, Barton SJ, Cudlip SA, Stubbs M, Saunders DE, Murphy M, Wilkins P, Opstad KS, Doyle VL, McLean MA, Bell BA, Griffiths JR. Metabolic profiles of human brain tumours using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2003;49:223-32.
13. Hetherington HP, Pan JW, Mason GF, Ponder SL, Twieg DB, Deutsch G, Mountz J, Pohost GM. 2D 1H spectroscopic imaging of the human brain at 4.1 T. Magn Reson Med 1994;32:530-4.
14. Behar KL, Rothman DL, Spencer DD, Petroff OAC. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med 1994;32:294-302.
15. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49-58.
16. Hugg JW, Kuzniecky RI, Gilliam FG, et al. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging. Ann Neurol 1996;40:236-9.
17. Leary SM, Brex PA, MacManus DG, Parker GJ, Barker GJ, Miller DH, Thompson AJ. A (1)H magnetic resonance spectroscopy study of ageing in parietal white matter: implications for trials in multiple sclerosis. Magn Reson Imaging 2000;18:455-9.
18. Brand A, Richter-Landsberg C, Liebfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993;15:289-98.
19. Bruhn H, Frahm J, Merboldt KD, Hanicke W, Hanefeld F, Christen HJ, Kruse B, Bauer HJ. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol 1992;32:140-50.
20. Woermann FG, McLean MA, Bartlett PA, et al. Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy. Brain 2001;124:427-36.
21. Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000;21:1645-9.
22. Pan JW, Mason GF, Pohost GM, Hetherington HP. Spectroscopic imaging of human brain glutamate by water-suppressed J-refocused coherence transfer at 4.1T. Magn Reson Med 1996;36:7-12.
23. Petroff OAC, Mattson RH, Rothman DL. Proton MRS: GABA and glutamate. In: TR Henry, JS Duncan, SF Berkovic, editors. Functional Imaging in the Epilepsies. Lippincott Williams and Wilkins: Philadelphia; 2000:261-271.
24. Pirzkall A, Nelson SJ, McKnight TR, Takahashi MM, Li X, Graves EE, Verhey LJ, Wara WW, Larson DA, Sneed PK. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 2002;53:1254-64.
25. Aboagye EO, Bujwalla ZM, Shungu DC, Glickson JD. Detection of tumor response to chemotherapy by 1H nuclear magnetic resonance spectroscopy: effect of 5-fluorouracil on lactate levels in radiation-induced fibrosarcoma 1 tumors. Cancer Res 1998;58:1063-7.
26. Tarnawski R, Sokol M, Pieniazek P, Maciejewski B, Walecki J, Miszcyzyk L, Krupska T. 1H-MRS in vivo predicts the early treatment oucome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 2002;52:1271-6.
27. Li X, Kin H, Lu Y, Oh J, Chang S, Nelson SJ. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed 2004;17:10-20.
28. Hofmann L, Slotboom J, Boesch C, Kreis R. Characterization of the macromolecule baseline in localized 1H-MR spectra of human brain. Magn Reson Med 2001;46:855-63.
29. McLean MA, Barker GJ. Concentrations and magnetization transfer ratios of metabolites in gray and white matter. Magn Reson Med 2006;56:1365-70.
30. Lai PH, Hsu SS, Ding SW, Ko CW, Fu JH, Weng MJ, Yeh LR, Wu MT, Liang HL, Chen CK, Pan HB. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions. Surg Neurol 2007;68(suppl 1):S25-S36.
31. Omuro AM, Leite CC, Mokhtari K, Delattre JY. Pitfalls in the diagnosis of brain tumours. Lancet Neurol 2006;5:937-48.
32. Luthra G, Parihar A, Nath K, Jaiswal S, Prasad KN, Husain N, Husain M, Singh S, Behari S, Gupta RK. Comparative evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and diffusion MR imaging and proton MR spectroscopy. AJNR Am J Neuroradiol 2007;28:1332-8.
33. Saindane AM, Cha S, Law M, Xue X, Knopp EA, Zagzag D. Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2002;23:1378-86.
34. Vuori K, Kankaanranta L, Hakkinen AM, et al. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology 2004;230:703-8.
35. Tate AR, Underwood J, Acosta DM, Julia-Sape M, Majos C, Moreno-Torres A, Howe FA, van der Graaf M, Lefournier V, Murphy MM, Loosemore A, Ladroue C, Wesseling P, Luc Bosson J, Cabanas ME, Simonetti AW, Gajewicz W, Calvar J, Capdevila A, Wilkins PR, Bell BA, Remy C, Heerschap A, Watson D, Griffiths JR, Arus C. Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra. NMR Biomed 2006;19:411-34.
36. Opstad KS, Bell BA, Griffiths JR, Howe FA. An investigation of human brain tumour lipids by high-resolution magic angle spinning 1H MRS and histological analysis. NMR Biomed 2007;20:1-9.
37. Jenkinson MD, Smith TS, Joyce K, Fildes D, du Plessis DG, Warnke PC, Walker C. MRS of oligodendroglial tumors: correlation with histopathology and genetic subtypes. Neurology 2005;64:2085-89.
38. Hall WA, Truwit CL. Intraoperative MR-guided neurosurgery. J Magn Reson Imaging 2008;27:368-75.
39. Hollingworth W, Medina LS, Lenkinski RE, Shibata DK, Bernal B, Zurakowski D, Comstock B, Jarvik JG. A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumours. AJNR 2006;27:1404-11.
40. Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, Verhey LJ, Dillon WP, Nelson SJ. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Radiat Biol Phys 2004;59:126-37.
41. Chuang CF, Chan AA, Larson D, Verhey LJ, McDermott M, Nelson SJ, Pirzkall A. Potential value of MR spectroscopic imaging for the radiosurgical management of patients with recurrent high-grade gliomas. Technol Cancer Res Treat 2007;6:375-82.
42. Cendes F, Andermann F, Dubeau F, et al. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology 1997;49:1525-33.
43. Willmann O, Wennberg R, May TW, Pohlmann-Eden B. The role of 1H magnetic resonance spectroscopy in pre-operative evaluation for epilepsy surgery. A meta-analysis. Epilepsy Res 2006;71:149-58.
44. Knowlton RC, Laxer KD, Ende G, Hawkins RA, Wong ST, Matson GB, Rowley HA, Fein G, Weiner MW. Presurgical multimodality neuroimaging in electroencephalo-graphic lateralized temporal lobe epilepsy. Ann Neurol 1997;42:829-37.
45. Serles W, Li LM, Antel SB, Cendes F, Gotman J, Olivier A, Andermann F, Dubeau F, Arnold DL. Time course of postoperative recovery of N-acetyl-aspartate in temporal lobe epilepsy. Epilepsia 2001;42:190-7.
46. Kuzniecky R, Palmer C, Hugg J, et al. Magnetic resonance spectroscopic imaging in temporal lobe epilepsy: neuronal dysfunction or cell loss?Arch Neurol 2001;58:2048-53.
47. Cross JH, Connelly A, Jackson GD, et al. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy. Ann Neurol 1996;39:107-13.
48. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30:424-37.
49. Mueller SG, Laxer KD, Barakos JA, Cashdollar N, Flenniken DL, Vermathen P, Matson GB, Weiner MW. Identification of the epileptogenic lobe in neocortical epilepsy with proton MR spectroscopic imaging. Epilepsia 2004;45:1580-9.
50. Woermann FG, McLean MA, Bartlett PA, Barker GJ, Duncan JS. Quantitative short echo time proton MRSI in malformations of cortical development causing epilepsy: widespread cortical and subcortical abnormalities. Brain 2001;124:427-36.
51. Cohen BA, Inglese M, Rusinek H, Babb JS, Grossman RI, Gonen O. Proton MR spectroscopy and MRI-volumetry in mild traumatic brain injury. AJNR Am J Neuroradiol 2007;28:907-13.
52. Gillard JH, Waldman AD, Barker PB. Clinical MR Neuroimaging: Diffusion, Perfusion and Spectroscopy. Cambridge: Cambridge University Press; 2004.